Try our Advanced Search for more refined results
May 05, 2010
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al
Case Number:
1:10-cv-03734
Court:
Nature of Suit:
Judge:
Firms
- Akin Gump
- Alston & Bird
- Axinn Veltrop
- Colucci & Umans
- Dahan Pampalone
- Eversheds Sutherland
- Goodwin Procter
- Jones Day
- Kasowitz Benson
- Knobbe Martens
- Latham & Watkins
- Maynard Nexsen
- Rakoczy Molino
- Ropes & Gray
Companies
- Allergan PLC
- Mallinckrodt PLC
- Noramco Inc.
- Purdue Pharma LP
- Ranbaxy
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 16, 2012
Actavis Tells Judge Purdue's Oxy Patents Rely On Minor Tweak
A chemical tweak should not allow Purdue Pharma LP to monopolize sales of the popular pain killer oxycodone for years, Actavis Elizabeth LLC argued Friday in a trial over whether Purdue's oxycodone patents should be killed.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login